Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. ALC
stocks logo

ALC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
2.71B
+8.47%
0.795
+10.46%
2.71B
+9.4%
0.831
+13.89%
2.77B
+6.78%
0.815
+7.24%
Estimates Revision
The market is revising Downward the revenue expectations for Alcon Inc. (ALC) for FY2025, with the revenue forecasts being adjusted by -0.12% over the past three months. During the same period, the stock price has changed by -1.47%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.12%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.39%
In Past 3 Month
Stock Price
Go Down
down Image
-1.47%
In Past 3 Month
Wall Street analysts forecast ALC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALC is 93.78 USD with a low forecast of 80.00 USD and a high forecast of 112.74 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast ALC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALC is 93.78 USD with a low forecast of 80.00 USD and a high forecast of 112.74 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
3 Hold
0 Sell
Strong Buy
Current: 78.990
sliders
Low
80.00
Averages
93.78
High
112.74
Current: 78.990
sliders
Low
80.00
Averages
93.78
High
112.74
Citi
Veronika Dubajova
Buy
downgrade
2025-11-28
Reason
Citi
Veronika Dubajova
Price Target
2025-11-28
downgrade
Buy
Reason
Citi analyst Veronika Dubajova lowered the firm's price target on Alcon to CHF 90 from CHF 91 and keeps a Buy rating on the shares.
Baird
Jeff Johnson
Outperform
maintain
$95 -> $98
2025-11-13
Reason
Baird
Jeff Johnson
Price Target
$95 -> $98
2025-11-13
maintain
Outperform
Reason
Baird analyst Jeff Johnson raised the firm's price target on Alcon to $98 from $95 and keeps an Outperform rating on the shares. The firm updated its model following Q3 results leading to increased conviction in 2026.
Mizuho
Anthony Petrone
Outperform
downgrade
$110 -> $100
2025-11-11
Reason
Mizuho
Anthony Petrone
Price Target
$110 -> $100
2025-11-11
downgrade
Outperform
Reason
Mizuho analyst Anthony Petrone lowered the firm's price target on Alcon to $100 from $110 and keeps an Outperform rating on the shares.
KeyBanc
Overweight
downgrade
$98 -> $91
2025-10-21
Reason
KeyBanc
Price Target
$98 -> $91
2025-10-21
downgrade
Overweight
Reason
KeyBanc lowered the firm's price target on Alcon to $91 from $98 to reflect challenging second half of 2025 setup, while keeping an Overweight rating on the shares. The firm continues to view Alcon as a key long-term idea but believes there may be limited upside to its second half of 2025 guidance.
Citi
Buy -> Buy
downgrade
$101 -> $91
2025-10-14
Reason
Citi
Price Target
$101 -> $91
2025-10-14
downgrade
Buy -> Buy
Reason
Citi lowered the firm's price target on Alcon to CHF 91 from CHF 101 and keeps a Buy rating on the shares.
Stifel
Thomas Stephan
Buy
downgrade
$90 -> $85
2025-09-29
Reason
Stifel
Thomas Stephan
Price Target
$90 -> $85
2025-09-29
downgrade
Buy
Reason
Stifel analyst Thomas Stephan lowered the firm's price target on Alcon to $85 from $90 and keeps a Buy rating on the shares. The firm, whose sales bridge analysis of core sales and new product sales suggests that second half upside remains unclear despite the recent guidance reduction, contends that "numbers still may not be fully reset," but still argues that the recent pullback in shares is "compelling." The firm believes the Street's 2026 EPS estimate needs to come down before shares can start to work in the near-term, but adds that valuation limits significant downside risk in the stock.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Alcon AG (ALC.N) is 24.27, compared to its 5-year average forward P/E of 29.53. For a more detailed relative valuation and DCF analysis to assess Alcon AG 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
29.53
Current PE
24.27
Overvalued PE
33.62
Undervalued PE
25.45

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average EV/EBITDA
17.80
Current EV/EBITDA
14.88
Overvalued EV/EBITDA
19.79
Undervalued EV/EBITDA
15.81

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
4.10
Current PS
3.56
Overvalued PS
4.49
Undervalued PS
3.71
Intellectia AI SwingMax
Intellectia AI SwingMax

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 470.5% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

ALC News & Events

Events Timeline

(ET)
2025-11-11
16:32:48
Alcon projects FY25 core EPS between $3.05 and $3.15, with consensus at $3.09.
select
2025-11-11
16:32:04
Alcon announces Q3 core EPS of 79 cents, falling short of consensus estimate of 85 cents.
select
2025-11-10 (ET)
2025-11-10
08:47:47
Staar Surgical Investor Discusses Changes to Sale Agreement with Alcon
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
12-04Yahoo Finance
2025 Intraocular Lens Market Competitor Analysis: Recent Developments, Strategies, Sustainability Benchmarks, Product Launches, Key Personnel, and Revenue Insights
  • Market Growth Projection: The intraocular lens (IOL) market is expected to grow from $4.46 billion in 2024 to $7.16 billion by 2033, with a compound annual growth rate (CAGR) of 5.41%, driven by the rising prevalence of cataracts and an aging population.

  • Technological Advancements: Innovations in lens technology, including multifocal and toric lenses, are enhancing visual outcomes and increasing the adoption of premium lens types, particularly in emerging markets.

  • Key Industry Players: Major companies like Alcon, Johnson & Johnson, and Bausch + Lomb are leading the market with new product launches and advancements, such as the Clareon Vivity IOL and the enVista Envy full-range IOL.

  • Sustainability Focus: The industry is increasingly prioritizing sustainability, with companies implementing environmental goals and initiatives related to renewable energy, waste management, and sustainable packaging.

[object Object]
Preview
6.0
11-24Benzinga
BTIG Affirms Buy Rating for Alcon, Keeps Price Target at $91
  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts to help traders stay informed and make timely decisions in the stock market.

  • Exclusive Content: Subscribers gain access to unique stories and insights generated by Benzinga reporters, enhancing their trading strategies.

  • Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, sharing knowledge and resources.

  • Market Winning Tools: The platform is designed to provide traders with the tools they need to succeed in the markets every day.

[object Object]
Preview
9.5
11-13Benzinga
Alcon's Stock Surges as New Eye Technology Gains Popularity
  • Third-Quarter Performance: Alcon Inc. reported third-quarter sales of $2.59 billion, a 6% year-over-year increase, slightly below the consensus estimate of $2.60 billion, while adjusted earnings of 79 cents exceeded expectations of 76 cents.

  • Growth Drivers: The growth was attributed to strong performance in surgical equipment and products, with notable traction from the Unity VCS and promising early uptake of the Tryptyr product.

  • Sales Breakdown: Surgical net sales reached $1.42 billion (up 6%), and Vision Care net sales were $1.2 billion (up 7%), with core operating income increasing to $523 million despite a slight decrease in core operating margin.

  • Future Outlook: Alcon affirmed its fiscal year 2025 adjusted earnings guidance of $3.05-$3.15 and maintained sales guidance of $10.3 billion to $10.4 billion, with expectations for core operating margin between 19.5% and 20.5%.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Alcon AG (ALC) stock price today?

The current price of ALC is 78.99 USD — it has decreased -1.3 % in the last trading day.

arrow icon

What is Alcon AG (ALC)'s business?

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

arrow icon

What is the price predicton of ALC Stock?

Wall Street analysts forecast ALC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALC is 93.78 USD with a low forecast of 80.00 USD and a high forecast of 112.74 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Alcon AG (ALC)'s revenue for the last quarter?

Alcon AG revenue for the last quarter amounts to 2.61B USD, increased 6.52 % YoY.

arrow icon

What is Alcon AG (ALC)'s earnings per share (EPS) for the last quarter?

Alcon AG. EPS for the last quarter amounts to 0.48 USD, decreased -9.43 % YoY.

arrow icon

What changes have occurred in the market's expectations for Alcon AG (ALC)'s fundamentals?

The market is revising Downward the revenue expectations for Alcon Inc. (ALC) for FY2025, with the revenue forecasts being adjusted by -0.12% over the past three months. During the same period, the stock price has changed by -1.47%.
arrow icon

How many employees does Alcon AG (ALC). have?

Alcon AG (ALC) has 25599 emplpoyees as of December 05 2025.

arrow icon

What is Alcon AG (ALC) market cap?

Today ALC has the market capitalization of 38.80B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free